These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K. Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010 [Abstract] [Full Text] [Related]
5. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B. Biochem J; 1999 Nov 15; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534 [Abstract] [Full Text] [Related]
6. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. Chambers MG, Cox L, Chong L, Suri N, Cover P, Bayliss MT, Mason RM. Arthritis Rheum; 2001 Jun 15; 44(6):1455-65. PubMed ID: 11407708 [Abstract] [Full Text] [Related]
7. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS. Osteoarthritis Cartilage; 2006 Feb 15; 14(2):101-13. PubMed ID: 16188468 [Abstract] [Full Text] [Related]
8. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis. Chevalier X, Claudepierre P, Groult N, Zardi L, Hornebeck W. J Rheumatol; 1996 Jun 15; 23(6):1022-30. PubMed ID: 8782135 [Abstract] [Full Text] [Related]
9. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. van Meurs J, van Lent P, Stoop R, Holthuysen A, Singer I, Bayne E, Mudgett J, Poole R, Billinghurst C, van der Kraan P, Buma P, van den Berg W. Arthritis Rheum; 1999 Oct 15; 42(10):2074-84. PubMed ID: 10524678 [Abstract] [Full Text] [Related]
10. Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures. Munteanu SE, Ilic MZ, Handley CJ. Arthritis Rheum; 2000 Oct 15; 43(10):2211-8. PubMed ID: 11037880 [Abstract] [Full Text] [Related]
11. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis. Lohmander LS. J Rheumatol Suppl; 1995 Feb 15; 43():75-7. PubMed ID: 7752145 [Abstract] [Full Text] [Related]
13. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration. Janusz MJ, Little CB, King LE, Hookfin EB, Brown KK, Heitmeyer SA, Caterson B, Poole AR, Taiwo YO. Osteoarthritis Cartilage; 2004 Sep 15; 12(9):720-8. PubMed ID: 15325638 [Abstract] [Full Text] [Related]
14. Calpain is involved in C-terminal truncation of human aggrecan. Struglics A, Hansson M. Biochem J; 2010 Sep 15; 430(3):531-8. PubMed ID: 20618160 [Abstract] [Full Text] [Related]
15. Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine. Swearingen CA, Carpenter JW, Siegel R, Brittain IJ, Dotzlaf J, Durham TB, Toth JL, Laska DA, Marimuthu J, Liu C, Brown DP, Carter QL, Wiley MR, Duffin KL, Mitchell PG, Thirunavukkarasu K. Osteoarthritis Cartilage; 2010 Sep 15; 18(9):1150-8. PubMed ID: 20633682 [Abstract] [Full Text] [Related]